Hims & Hers Health (HIMS) Assets Average (2019 - 2026)
Hims & Hers Health (HIMS) reported Assets Average of $2.2 billion for Q1 2026, up 176.49% on a YoY basis from $799.6 million in Q1 2025, and up 0.77% sequentially from $2.2 billion in Q4 2025.
Hims & Hers Health (HIMS) Assets Average (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Assets Average data on file, last reported at $2.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 176.49% year-over-year to $2.2 billion; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 176.49% YoY), and the FY2025 full-year result was $1.4 billion, up 149.17% from the prior year.
- Assets Average improved to $2.2 billion in Q1 2026, from $2.2 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $2.2 billion in Q1 2026 to a low of $371.3 million in Q1 2023.
- A 5-year average of $816.0 million and a median of $444.6 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average dropped 10.88% in 2022 and surged 279.67% in 2025, its largest moves.
- Tracing HIMS's Assets Average over 5 years: stood at $374.6 million in 2022, then advanced by 14.13% to $427.5 million in 2023, then soared by 53.18% to $654.9 million in 2024, then surged by 235.01% to $2.2 billion in 2025, then grew by 0.77% to $2.2 billion in 2026.
- Business Quant data shows HIMS's Assets Average at $2.2 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 7.30 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | 21.86 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 2.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.21 Bn |
| Dec 31, 2025 | 2.19 Bn |
| Sep 30, 2025 | 2.06 Bn |
| Jun 30, 2025 | 1.38 Bn |
| Mar 31, 2025 | 799.63 Mn |
| Dec 31, 2024 | 654.90 Mn |
| Sep 30, 2024 | 541.38 Mn |
| Jun 30, 2024 | 464.30 Mn |
| Mar 31, 2024 | 444.65 Mn |
| Dec 31, 2023 | 427.53 Mn |
| Sep 30, 2023 | 401.87 Mn |
| Jun 30, 2023 | 383.10 Mn |
| Mar 31, 2023 | 371.32 Mn |
| Dec 31, 2022 | 374.58 Mn |
| Sep 30, 2022 | 381.40 Mn |
| Jun 30, 2022 | 381.00 Mn |
| Mar 31, 2022 | 401.31 Mn |
| Dec 31, 2021 | 420.33 Mn |
| Sep 30, 2021 | 383.88 Mn |
| Jun 30, 2021 | 346.80 Mn |